Predicting the risk of clinically significant intraocular lens tilt and decentration in vitrectomized eyes.

Preoperative crystalline lens tilt and decentration showed strong predictive ability for postoperative clinically significant tilt and decentration of the intraocular lens in vitrectomized eyes. Purpose: To identify predictors and develop a prognostic nomogram for clinically significant intraocular lens (IOL) tilt and decentration in vitrectomized eyes. Setting: Zhongshan ophthalmic center, Guangzhou, China. Design: Prospective observational study. Methods: Patients with previous pars plana vitrectomy who underwent phacoemulsification with IOL implantation were enrolled in this study. The tilt and decentration of the lens and IOL were assessed by a swept-source anterior segment optical coherence tomography (CASIA2). Multiple logistic regression analysis and prognostic nomogram models were used to explore factors associated with clinically significant IOL tilt and decentration (defined as tilt ≥7 degrees and decentration ≥0.4 mm). Results: 375 patients (375 eyes) with a mean age of 56.1 ± 9.81 years were included. Lens tilt (odds ratio [OR] = 1.44), lens decentration (OR = 1.74), lens diameter (OR = 0.49), and hydrophilic IOL (OR = 2.36) were associated with IOL tilt over 7 degrees (all P <.05). Lens tilt (OR = 1.24), lens decentration (OR = 2.30), and incomplete capsulorhexis–IOL overlap (OR = 2.44) increased the risk of IOL decentration over 0.4 mm (all P <.05). Preoperative lens tilt together with lens decentration was identified as the strongest predictor of incident clinically significant IOL tilt (area under the curve [AUC] = 0.82, 95% CI, 0.76-0.88) and decentration (AUC: 0.84, 95% CI, 0.78-0.89), and the nomogram was constructed accordingly. Conclusions: The tilt and decentration of the crystalline lens, hydrophilic IOL, and incomplete capsulorhexis–IOL overlap were risk factors for clinically significant IOL misalignment. Clinicians could use a prognostic nomogram model based on the preoperative lens position to make a strategy for higher-risk patients. [ABSTRACT FROM AUTHOR]